Endotoxin testing of proteins for parenteral administration using the Mono Mac 6 assay

L Moesby1, E W Hansen, J D Christensen

  • 1Department of Pharmacology, The Royal Danish School of Pharmacy, 2 Universitetsparken, 2100 Copenhagen, Denmark. LM@mail.dfh.dk

Abstract

Insights

The Mono Mac 6 cell line assay reliably quantifies endotoxin in protein-based pharmaceuticals. This method overcomes interference issues, offering a dependable alternative for pyrogen testing in sensitive protein products.

Area of Science:

  • Biotechnology
  • Pharmaceutical Analysis
  • Cell-based Assays

Background:

  • Protein-based pharmaceuticals pose challenges for traditional endotoxin and pyrogen testing.
  • The Limulus Amebocyte Lysate (LAL) test is often interfered with by proteins.
  • Rabbit immunogenicity tests present ethical and practical limitations.

Purpose of the Study:

  • To assess the efficacy of the Mono Mac 6 monocytic cell line assay for endotoxin detection in protein pharmaceuticals.
  • To evaluate the quantitative accuracy of the Mono Mac 6 assay for endotoxin levels in specific protein products.

Main Methods:

  • Quantitative evaluation of endotoxin detection in human albumin, gamma-globulin, and somatropin using the Mono Mac 6 assay.
  • Investigating and addressing protein interference with the assay.

Main Results:

  • The Mono Mac 6 assay demonstrated a detection limit well below European Pharmacopoeia thresholds for all tested proteins.
  • Interference from two protein products was observed but successfully managed through product dilution or using protein-specific standard curves.
  • The assay proved effective for quantitative endotoxin determination in the presence of proteinaceous substances.

Conclusions:

  • The Mono Mac 6 assay is a robust and reliable method for the quantitative detection of endotoxin in protein-containing pharmaceutical products.
  • This cell-based assay offers a viable alternative to conventional pyrogen testing methods for complex biological drugs.